Laurus Labs Ltd. (LAURUSLABS): Laurus Labs Share Price rises 3.09% as stock trades at Rs 1,926

Laurus Labs Share Price is trading at Rs 1,926, up 3.09% from the previous close, with market capitalisation at Rs 99,417.45 Cr. The stock moved higher in today’s market trade, and the latest Univest data confirms the price rise without establishing a company-specific catalyst. For investors tracking Laurus Labs Share Price Today, the move matters because it combines a firmer price action with a large-cap valuation profile in the Healthcare sector. Laurus Labs Share Price News is therefore drawing attention not only for the day’s gain, but also for how the company is valued on PE, PB and return ratios against pharma peers. In a market led by selective stocks in news, the key question is whether today’s share price rise reflects durable investor interest or only a short-term move.

Laurus Labs Share Price Today: Price Action Analysis

Laurus Labs Ltd. (LAURUSLABS) rose to Rs 1,926 from the previous close of Rs 1,868.25, a move of Rs 57.75 or 3.09%. The stock opened at Rs 1,872.7, reached a high of Rs 1,933.9, recorded a low of Rs 1,865.

Laurus Labs Share Price today opened at Rs 1,872.70, moved between Rs 1,865 and Rs 1,933.90, and last traded at Rs 1,926. The day’s gain of Rs 57.75 over the previous close of Rs 1,868.25 shows a clear share price rise, while turnover stood at Rs 4.77 Cr. For readers following Laurus Labs Share Price Live and Laurus Labs Share Price Update, the move places the stock among the active market movers in the Indian stock market. The price action shows that Laurus Labs Share Price Today stayed above the opening level and near the upper end of the range, which is why it is showing up in Stocks Rising Today and Top Gainers Today searches. According to latest Univest data, the event is confirmed, while the specific cause remains unverified.

Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis

Laurus Labs Ltd. (LAURUSLABS) fundamental metrics show P/E 92.32x, P/B 17.9x, ROE 18.31%, ROCE 18.2%. These figures provide context only and are not a buy or sell signal.

Laurus Labs Ltd. has a market capitalisation of Rs 99417.45 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 92.32x, P/B at 17.9x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.31% and ROCE of 18.2%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 20.24, book value per share of Rs 104.37, dividend yield of 0.11%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.52x, median ROE of 11.82%, median ROCE of 13.71%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Laurus Labs Ltd. (LAURUSLABS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 92.32x, which is above the benchmark median of 32.52x, a difference of +183.89%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Laurus Labs Ltd. (LAURUSLABS) has a ROE of 18.31%, which is above the benchmark median of 11.82%, a difference of +54.91%. Laurus Labs Ltd. (LAURUSLABS) has a ROCE of 18.2%, which is above the benchmark median of 13.71%, a difference of +32.75%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 92.32x compared with the displayed peer median of 37.69x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.31% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 18.2% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Laurus Labs Ltd. (LAURUSLABS) has a market capitalisation of Rs 99,417.45 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

Why Investors Are Watching Laurus Labs

• Laurus Labs Share Price rose 3.09% to Rs 1,926, so the stock is clearly in today’s market conversation.
• The day’s range, from Rs 1,865 to Rs 1,933.90, keeps Laurus Labs Share Price close to the upper side of intraday trade.
• Valuation remains a central focus because PE at 92.32 and PB at 17.9 are well above the industry benchmark.
• ROE at 18.31% and ROCE at 18.2% give the stock a stronger profitability profile than many peers.
• Large-cap status with market cap of Rs 99,417.45 Cr keeps Laurus Labs Stock News relevant for healthcare investors.

About Laurus Labs

Laurus Labs Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector, and Laurus Labs Share Price reflects market interest in its business scale and operating profile. The company is followed on both NSE and BSE as a listed pharma name with a large market capitalisation. Its earnings profile is captured through EPS of 20.24, while book value of Rs 104.37 and dividend yield of 0.11% add further context to Laurus Labs Fundamental Analysis. For readers tracking Laurus Labs Stock Performance, the company’s valuation and profitability ratios matter because they influence how the market weighs the business against peers. Laurus Labs Share News typically attracts attention when price action, sector sentiment and valuation all come into view at the same time. In that sense, Laurus Labs Share Price Today is being read as both a market update and a financial analysis story.

Frequently Asked Questions

Why is Laurus Labs Share Price rising today?

Ans. Laurus Labs Share Price is rising today because the stock gained 3.09% to Rs 1,926. The latest Univest figures confirm the price event, but they do not establish a company-specific catalyst.

What is Laurus Labs Share Price Today?

Ans. Laurus Labs Share Price Today is Rs 1,926, which is Rs 57.75 above the previous close of Rs 1,868.25. The move keeps the stock in focus among healthcare market updates.

How much did Laurus Labs share price rise in today’s trade?

Ans. Laurus Labs Share Price rose 3.09% in today’s trade. The stock opened at Rs 1,872.70 and moved as high as Rs 1,933.90, showing a firm intraday recovery. The previous close was Rs 1,868.25.

What is the market capitalisation of Laurus Labs?

Ans. Laurus Labs has a market capitalisation of Rs 99,417.45 Cr. That places the company among the large-cap names in the Healthcare sector and supports its visibility in market news.

Is Laurus Labs expensive compared with pharma peers?

Ans. Laurus Labs Share Price carries a PE of 92.32 and PB of 17.9, both above the industry benchmark. That makes the stock appear richer than many pharma peers on simple valuation ratios.

What do Laurus Labs EPS and book value show?

Ans. Laurus Labs reports EPS of 20.24 and book value of Rs 104.37. EPS shows earnings attributable to each share, while book value reflects the accounting net worth behind each share.

How do Laurus Labs ROE and ROCE compare with the industry?

Ans. Laurus Labs has ROE of 18.31% and ROCE of 18.2%, both above the industry median and average. That indicates stronger efficiency than the broader pharmaceuticals and drugs benchmark set.

Should investors track Laurus Labs Share Price on Univest?

Ans. Investors tracking Laurus Labs Share Price can use Univest for price updates, valuation ratios, sector context and company news. It offers a quick way to follow the stock’s market position.

Track Laurus Labs Share Price on Univest

Use Laurus Labs Ltd. (LAURUSLABS) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Track Laurus Labs Share Price on Univest for live share price updates, market cap, PE ratio, PB ratio, EPS, book value, dividend yield, 52-week levels and market insights. Univest also helps readers compare Laurus Labs Stock Analysis with pharma peers, sector benchmarks and the latest company news.